DVx Overview
- Year Founded
-
1986
- Status
-
Public
- Employees
-
347
- Stock Symbol
-
3079
- Investments
-
2
- Share Price
-
$6.35
- (As of Friday Closing)
DVx General Information
Description
DVx Inc is engaged in manufacture, sale, repair, and leasing of medical equipment and related peripheral equipment, research and development of medical equipment, provide in house and out of service consulting services and services for medical and medical devices, and providing medical publication and market research.
Contact Information
Website
www.dvx.jpCorporate Office
- Mejiro Nakano Building, 5th Floor
- 2-17-22 Takada, Toshima-ku
- Tokyo, Toshima-ku 171-0033
- Japan
Corporate Office
- Mejiro Nakano Building, 5th Floor
- 2-17-22 Takada, Toshima-ku
- Tokyo, Toshima-ku 171-0033
- Japan
DVx Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$6.35 | $6.35 | $6.17 - $7.63 | $66.4M | 10.4M | 7.17K | $0.11 |
DVx Financials Summary
In Thousands, USD |
TTM 31-Mar-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
---|---|---|---|---|
EV | 17,169 | 17,169 | 13,102 | 24,877 |
Revenue | 317,331 | 317,331 | 350,740 | 404,976 |
EBITDA | 5,585 | 5,585 | 12,858 | 14,463 |
Net Income | 1,197 | 1,197 | 6,915 | 7,682 |
Total Assets | 149,844 | 149,844 | 177,040 | 181,984 |
Total Debt | 83 | 83 | 77 | 0 |
DVx Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
DVx Patents
DVx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2021115220-A | Catheter and fixing tool of guide wire | Pending | 24-Jan-2020 | ||
JP-7144464-B2 | Contrast injection device and injection line kit | Active | 20-Jan-2020 | ||
AU-2021210280-A1 | Contrast medium injection device and injection line kit | Pending | 20-Jan-2020 | ||
CA-3164400-A1 | Contrast medium injection device and injection line kit | Pending | 20-Jan-2020 | ||
JP-2021112410-A | Contrast medium injector and injection line kit | Active | 20-Jan-2020 | A61M5/007 |
DVx Executive Team (1)
Name | Title | Board Seat |
---|---|---|
Hiroshi Shibasaki | Representative Director, President & Chief Executive Officer |
DVx Signals
DVx Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
ICorNet | 29-Mar-2021 | Therapeutic Devices | |||
ICorNet | 05-Feb-2018 | Seed Round | Therapeutic Devices |
DVx ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Distribution
Subindustry
Rank
Percentile
DVx FAQs
-
When was DVx founded?
DVx was founded in 1986.
-
Who is the CEO of DVx?
Hiroshi Shibasaki is the CEO of DVx.
-
Where is DVx headquartered?
DVx is headquartered in Tokyo, Japan.
-
What is the size of DVx?
DVx has 347 total employees.
-
What industry is DVx in?
DVx’s primary industry is Distributors (Healthcare).
-
Is DVx a private or public company?
DVx is a Public company.
-
What is DVx’s stock symbol?
The ticker symbol for DVx is 3079.
-
What is the current stock price of DVx?
As of 04-Oct-2024 the stock price of DVx is $6.35.
-
What is the current market cap of DVx?
The current market capitalization of DVx is $66.4M.
-
What is DVx’s current revenue?
The trailing twelve month revenue for DVx is $317M.
-
What is DVx’s annual earnings per share (EPS)?
DVx’s EPS for 12 months was $0.11.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »